Rhumbline Advisers Has $40.51 Million Position in Biogen Inc. $BIIB

NodeGuardian · 2026-02-23T04:34:48+00:00

Rhumbline Advisers reduced its Biogen Inc. stake by 3.6%, holding 289,206 shares worth $40.51 million. Despite a revenue decline, Biogen exceeded earnings expectations and provided positive guidance for FY2026. Institutional ownership is high at 87.93%.

NodeGuardian

2026-02-23 04:34:48

Abstract generation in progress

Rhumbline Advisers reduced its stake in Biogen Inc. by 3.6% in the third quarter, now holding 289,206 shares valued at $40.51 million. Despite a 7.2% year-over-year revenue decline, Biogen surpassed quarterly earnings estimates and provided optimistic FY2026 guidance. Institutional ownership remains high at 87.93%, with several major investment firms adjusting their positions, and analysts have issued various ratings for the stock.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes